Hot Investor Mandate: Western Europe Investment Firm Seeks Early-Stage Biotech & Medtech Companies, Preferably With Ties to Europe, Investing Up to $10M

6 May

A Western Europe based venture capital firm provides university spin-offs as well as other promising start-up companies with capital, coaching and networks. The firm is an advisor to multiple funds, and is investing in a variety of technological industries; about 50% of the portfolio is in the life science sector. The firm makes allocations from $500,000 to $10M over the life of the investment, and in the life science sector allocations are typically over $5m. The firm primarily invests in companies based in Europe or with ties to Europe. Allocations to US, Canada and Israel are possible.

The firm invests in the biotech and medtech sectors and is opportunistic within these sectors regarding indication area and technology. The firm prefers to invest in early-stage companies, with assets ranging from preclinical to mid-stage clinical trials (Phase II for therapeutics).

The firm seeks highly qualified, ambitious management teams, and is typically an activist investor that takes a seat on a portfolio company’s board.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: